Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine

Basic information Safety Supplier Related

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine Basic information

Product Name:
4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine
Synonyms:
  • 4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine
  • 1H-Pyrrolo[2,3-c]pyridine, 4-broMo-7-chloro-
  • 4-BroMo-7-chloro-6-azaindole
CAS:
425380-38-7
MF:
C7H4BrClN2
MW:
231.48
EINECS:
200-589-5
Mol File:
425380-38-7.mol
More
Less

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine Chemical Properties

Melting point:
230-231°
Boiling point:
367.8±37.0 °C(Predicted)
Density 
1.878±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
12.15±0.40(Predicted)
Appearance
Off-white to yellow Solid
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2933998090
More
Less

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine Usage And Synthesis

Uses

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine inhibits HIV replication in vitro and has shown to be active against both wild type and drug resistant strains of HIV. It also has potential for use as a prophylaxis agent.

Biological Activity

4-Bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine is an azaindole with antiviral activity against HIV. It have been shown to be potent inhibitors of the HIV protease enzyme.

Synthesis

67443-38-3

1826-67-1

425380-38-7

Vinylmagnesium bromide (400 mL, 1.0 M solution in THF) was slowly added dropwise to a stirred solution of 5-bromo-2-chloro-3-nitropyridine (20 g, 84.74 mmol) in anhydrous THF (800 mL) at -78 °C. The reaction mixture was slowly warmed to -20 °C and stirred continuously at this temperature for 8 hours. Upon completion of the reaction, the reaction was quenched with 20% NH4Cl solution (600 mL), followed by extraction of the product with ethyl acetate (2 x 500 mL). The organic layers were combined, washed sequentially with water (200 mL) and brine (200 mL), dried over anhydrous sodium sulfate and concentrated. The resulting crude product was ground with ether (2 × 100 mL) to afford 4-bromo-7-chloro-1H-pyrrolo[2,3-C]pyridine as a brown solid (8 g, 40% yield).1H NMR (400 MHz, DMSO-d6) δ 12.48 (br s, 1H), 8.07 (s, 1H), 7.82 (t, J = 3.2 Hz, 1H), 6.61 (s, 1H); LC/MS: m/z 232 [M+H]+.

References

[1] Patent: WO2014/125408, 2014, A2. Location in patent: Page/Page column 36
[2] Journal of Organic Chemistry, 2002, vol. 67, # 7, p. 2345 - 2347
[3] Patent: WO2014/210255, 2014, A1. Location in patent: Page/Page column 282
[4] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 23, p. 5439 - 5445
[5] Journal of Medicinal Chemistry, 2018, vol. 61, # 14, p. 6308 - 6327

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine Preparation Products And Raw materials

Raw materials

4-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridineSupplier

PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
China Langchem Inc.
Tel
0086-21-58956006
Shanghai AmasPharm Co., Ltd.
Tel
021-54540637 18621091017
Email
sales@amaspharm.com